Emmie Longshore
Nurse Practitioner · Ranburne, ALNPI 1184171886
Payments from drug & device makers
Across 209 payments — averaging $14.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$473
- Lilly USA, LLC$221
- Novartis$130
- Otsuka America Pharmaceutical, Inc.$122
- Amgen$111
- plus $711 from 20 others
What the payments were for
- Food & beverage$3,112100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 111 | $1,345 |
| Novo Nordisk | 24 | $473 |
| Lilly USA, LLC | 13 | $221 |
| Novartis | 8 | $130 |
| Otsuka America Pharmaceutical, Inc. | 7 | $122 |
| Amgen | 8 | $111 |
| Biohaven Pharmaceuticals, Inc. | 4 | $95 |
| Shield Therapeutics Inc | 4 | $82 |
| GSK | 5 | $76 |
| Xeris Pharmaceuticals, Inc. | 3 | $67 |
| Pfizer | 3 | $56 |
| Exact Sciences | 2 | $40 |
| IBSA Pharma Inc. | 2 | $36 |
| Lundbeck LLC | 2 | $29 |
| Astellas Pharma US Inc | 2 | $29 |
| Boston Scientific | 1 | $27 |
| Mayne Pharma Commercial LLC | 1 | $26 |
| Abbott | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Linus Health, Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $13 |
| Acella Pharmaceuticals, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$125
How this compares
$3,112 in reported general payments places this provider in the 85th percentile of 1,505 nurse practitioner providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 19 | $17,781 |
| JardianceEmpagliflozin | 11 | $11,856 |
| Ranolazine ErRanolazine | 15 | $710 |
| Levothyroxine Sodium | 95 | $640 |
| Omeprazole | 41 | $453 |
| Gabapentin | 23 | $442 |
| Trazodone Hcl | 38 | $350 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 17 | $317 |
| Bupropion XlBupropion Hcl | 22 | $301 |
| Fluticasone Propionate | 39 | $281 |
| Atorvastatin Calcium | 45 | $266 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $236 |
| Potassium Chloride | 13 | $228 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $201 |
| Metoprolol Succinate | 36 | $201 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $473 | $17,78119 claims |
| Boehringer IngelheimJardiance | $18 | $11,85611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,505 nurse practitioner providers in Alabama.
Other nurse practitioner in Ranburne
- Erin TannerAlabaster$141K
- Ardie Pack MabienMobile$126K
- Ginger McDanielBirmingham$27K
- Audrey MorganMontgomery$24K
- Hollie CrutchfieldDothan$22K
- Leah GravesBirmingham$21K
- Lauren DowneyBirmingham$19K
- Ashley HodgensMontgomery$19K
- Lisa PeoplesBirmingham$17K
- Samantha WeaverBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.